Behcet's syndrome: Literature review

Current Rheumatology Reviews

Volumn 5, Issue 1, 2009, Pages 64-82

  Tunes, Roberto ^a   Santiago, Mittermayer ^b,c  

^a Hospital Espanhol   (Brazil)

^b HOSPITAL SANTA IZABEL   (Brazil)

^c NONE   (Brazil)

Author keywords

Behcet's syndrome; Epidemiology; Pathogenesis; Treatment

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ALPHA2A INTERFERON; ANTICOAGULANT AGENT; AZATHIOPRINE; BENZATHINE PENICILLIN; BETAMETHASONE; CHLORAMBUCIL; CLOBETASOL; CLOBETASOL PROPIONATE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; FLUOCINOLONE; INFLIXIMAB; INTERFERON; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; PENTOXIFYLLINE; PLACEBO; PREDNISOLONE; PREDNISONE; SUCRALFATE; TACROLIMUS; THALIDOMIDE; TRIAMCINOLONE; UNINDEXED DRUG;

ACNE; AGRANULOCYTOSIS; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ANTIBIOTIC THERAPY; ARTERY DISEASE; ARTHRITIS; ARTHROPATHY; BEHCET DISEASE; BLOOD DYSCRASIA; BONE MARROW TOXICITY; CEREBRAL SINUS THROMBOSIS; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DRUG EFFICACY; ERYTHEMA NODOSUM; ERYTHROCYTE SEDIMENTATION RATE; EYE DISEASE; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; GENITAL ULCER; GEOGRAPHIC DISTRIBUTION; GINGIVA HYPERPLASIA; GOUT; HEMOLYSIS; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; INCIDENCE; INFERTILITY; KIDNEY FAILURE; LEUKOPENIA; LIVER TOXICITY; METHEMOGLOBINEMIA; MOUTH ULCER; NAUSEA; NEOPLASM; NEUROLOGIC DISEASE; NEUROTOXICITY; PATHOGENESIS; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SKIN ATROPHY; SKIN ULCER; STREPTOCOCCUS; THROMBOEMBOLISM; UVEITIS; VASCULAR DISEASE; VASCULITIS; VOMITING; WEIGHT REDUCTION;

EID: 65949123809     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339709787315357     Document Type: Review

References (149)

1. Marshall SE. Behcet's disease. Best Pract Res Clin Rheumatol 2004; 18(3): 291-311.
2. Eguia A, Villarroel M, Martinez-Conde R, Echebarria MA, Aguirre JM. Adamantiades-Behcet disease: an enigmatic process with oral manifestations. Med Oral Patol Oral Cir Bucal 2006; 11(1): E6-E11.
3. Zouboulis CC, Kaklamanis P. Early descriptions of Adamantiades-Behcet's disease. Ann Rheum Dis 2003; 62(7): 691-92.
4. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 2005; 52(3 Pt 1): 500-08.
5. Gul A. Behcet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S6-S12.
6. Gul U, Gonul M, Cakmak SK, Kilic A, Olcay I. Atopy in Behcet's disease. Int J Dermatol 2006; 45(8): 1011-13.
7. Yurdakul S, Gunaydin I, Tuzun Y, et al. The prevalence of Behcet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15(5): 820-22.
8. Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol 2003; 42(10): 803-06.
9. Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 1997; 38(6): 411-22.
10. Kotulska A, Kucharz EJ, Kopec M. Behcet's disease in Poland. Clin Rheumatol 2005; 24(6): 667-68.
11. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol 2003; 42(5): 346-51.
12. Aguiar SB, Guimarães S, Mesquita M, et al. Doença de Behçet: estudo de 22 casos. Rev Bras Reumatol 1997; 37(2): 66-74.
13. Coimbra AMV, Fernandes SRM, Costallat LTL, Samara AM. Síndrome de Behçet: apresentação de dez casos e revisão da literatura. Rev Bras Reumatol 1989; 29(3): 105-10.
14. Vitral NP, Scherrer MA, Bambirra E, Oréfice F. Estudos de parâmetros clinico-laboratoriais em pacientes portadores da doença de behçet. Rev Bras Oftalmol 2000; 59(1): 58-67.
15. Green AL, Mitchell PJ. Spinal cord Neurobehcet's disease detected on magnetic resonance imaging. Australas Radiol 2000; 44(2): 201-03.
16. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behcet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 2006; 25(3): 364-67.
17. Houman MH, Ben GI, Khiari BS, I, Lamloum M, Ben AM, Miled M. Deep vein thrombosis in Behcet's disease. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S48-S50.
18. Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30(11): 943-48.
19. Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL. Malignancy in Behcet's disease: a report of 13 cases and a review of the literature. Clin Rheumatol 2001; 20(4): 239-44.
20. Zouboulis CC, Vaiopoulos G, Marcomichelakis N, et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet's disease in Greece. Clin Exp Rheumatol 2003; 21(4 Suppl 30): S19-S26.
21. Lee S. Diagnostic criteria of Behcet's disease: problems and suggestions. Yonsei Med J 1997; 38(6): 365-69.
22. James DG. Silk Route disease. Postgrad Med J 1986; 62(725): 151-53.
23. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100(9): 1455-58.
24. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54(3): 213-20.
25. Zouboulis CC. Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne (Paris) 1999; 150(6): 488-98.
26. Barra C, Belfort JR, Abreu MT, Kim MK, Martins MC, Petrilli AM. Behcet's disease in Brazil - a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991; 35(3): 339-46.
27. Mok CC, Cheung TC, Ho CT, Lee KW, Lau CS, Wong RW. Behcet's disease in southern Chinese patients. J Rheumatol 2002; 29(8): 1689-93.
28. Davatchi F, Jamshidi A, Banihashemi AT, et al. Prevalence of Behcet's disease in Iran: a WHO-ILAR COPCORD stage I study. APLAR J Rheumatol 2007; 10: 239-43.
29. Bang D, Lee JH, Lee ES, et al. Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study. J Korean Med Sci 2001; 16(5): 615-18.
30. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I. Epidemiologic and clinical aspects of Behcet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol 2000; 27(3): 703-07.
31. Hirohata T, Kuratsune M, Nomura A, Jimi S. Prevalence of Behcet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J 1975; 34(7): 244-46.
32. Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet's disease in the north of Israel. Clin Rheumatol 2007; 26(4): 555-60.
33. Papoutsis NG, Abdel-Naser MB, Altenburg A, et al. Prevalence of Adamantiades-Behcet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 2006; 24(5 Suppl 42): S125.
34. Krause I, Mader R, Sulkes J, et al. Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28(5): 1033-36.
35. Albino GC, Grumann Júnior A, Rocha AWD. Perfil Epidemiológico de Uveítes no Hospital Regional de São José. ACM arq catarin med 1996; 25(4): 321-25.
36. Garcia CADA, Gomes AHB, Barbosa MFdA, Rocha MLR, Uchôa RAC. Aspectos clínicos e epidemiológicos das uveítes em Natal - RN. Rev Bras Oftalmol 2002; 61(2): 121-29.
37. Gomi CF, Makdissi FF, Yamamoto JH, Olivalves E. Estudo epidemiologico das uveites. Rev med (São Paulo) 1997; 76(2): 101-08.
38. Gouveia E, Yamamoto J, Abdall M, Hirata C, Kubo P, Olivalves E. Causas das uveétes em seviço terciário em São Paulo, Brasil. Arq Bras Oftalmol 2004; 67: 139-45.
39. Davatchi F, Shahram F, Kumar A, Cheng YK, Cheong CT, Bendrups A. Comparative analysis of Behçet's disease in APLAR region. APLAR J Rheumatol 2004; 7: 38-43.
40. Scherrer MAR, Oréfice F. Contribuição ao estudo das manifestações dermatológicas e oftalmológicas da Síndrome de Behçet. Arq Bras Oftalmol 1988; 51(4): 149-55.
41. Lacerda RR. Doença de Behçet - Estudo Clínico e Imunológico - Acompanhamento de 42 Casos ao Longo de Dez Anos - Estudo Sequencial. Rev Bras Oftalmol 1992; 51(2): 9-19.
42. Chen YC, Chang HW. Clinical characteristics of Behcet's disease in southern Taiwan. J Microbiol Immunol Infect 2001; 34(3): 207-10.
43. Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N. Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 2004; 31(1): 133-39.
44. Rossi C, Sato E. Doença de Behçet: aspectos etiopatogênicos. Rev Bras Reumatol 2001; 41(3): 167-73.
45. Kontogiannis V, Powell RJ. Behcet's disease. Postgrad Med J 2000; 76(900): 629-37.
46. Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 1991; 34(1): 39-43.
47. Bang D, Cho YH, Choi HJ, Lee S, Sohn S, Lee ES. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behçet's disease. Rev Rhum Engl 1996; 63: 532.
48. Sohn S, Lee ES, Bang D, Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 1998; 8(1): 21-3.
49. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60(11): 996-1002.
50. Celenligil-Nazliel H, Kansu E, Ebersole JL. Periodontal findings and systemic antibody responses to oral microorganisms in Behcet's disease. J Periodontol 1999; 70(12): 1449-56.
51. Mumcu G, Ergun T, Inanc N, et al. Oral health is impaired in Behcet's disease and is associated with disease severity. Rheumatology (Oxford) 2004; 43(8): 1028-33.
52. Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies. A novel serologic marker for Behcet's disease. Adv Exp Med Biol 2003; 528: 201-04.
53. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol 2003; 21(4 Suppl 30): S44-S8.
54. Yurdakul S, Hamuryudan V, Yazici H. Behcet syndrome. Curr Opin Rheumatol 2004; 16(1): 38-42.
55. Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH. HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S31-S5.
56. Choukri F, Chakib A, Himmich H, Marih L, Caillat-Zucman S. HLA-B phenotype modifies the course of Behcet's disease in Moroccan patients. Tissue Antigens 2003; 61(1): 92-6.
57. Kera J, Mizuki N, Ota M, et al. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behcet's disease in Italian patients. Tissue Antigens 1999; 54(6): 565-71.
58. Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens 2004; 64(3): 293-97.
59. Mizuki N, Ota M, Katsuyama Y, et al. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease. Tissue Antigens 2001; 57(5): 457-62.
60. Paul M, Klein T, Krause I, Molad Y, Narinsky R, Weinberger A. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behcet's disease. Tissue Antigens 2001; 58(3): 185-86.
61. Neves F, Moraes J, Gonçalves C. Síndrome de Behçet: à procura de evidências. Rev Bras Reumatol 2006; 46(1): 21-9.
62. Mizuki N, Inoko H, Ohno S. Molecular genetics (HLA) of Behcet's disease. Yonsei Med J 1997; 38(6): 333-49.
63. Mizuki N, Inoko H, Ohno S. Pathogenic gene responsible for the predisposition of Behcet's disease. Int Rev Immunol 1997; 14(1): 33-48.
64. Mizuki N, Ohno S. Immunogenetic studies of Behcet's disease. Rev Rhum Engl Ed 1996; 63(7-8): 520-7.
65. Park KS, Min K, Nam JH, Bang D, Lee ES, Lee S. Association of HYPA haplotype in the mannose-binding lectin gene-2 with Behcet's disease. Tissue Antigens 2005; 65(3): 260-65.
66. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behcet's disease: immunological aspects. Yonsei Med J 1997; 38(6): 350-58.
67. Emmi L, Brugnolo F, Marchione T. Pathogenesis and therapy of Behcet's disease. Ann Ital Med Int 1997; 12(1): 20-5.
68. Demirer S, Sengul N, Yerdel MA, et al. Haemostasis in patients with Behcet's disease. Eur J Vasc Endovasc Surg 2000; 19(6): 570-74.
69. Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dundar SV, Kirazli S. Impaired haemostatic kinetics and endothelial function in Behcet's disease. J Intern Med 1996; 240(4): 181-87.
70. Kiraz S, Ertenli I, Calguneri M, et al. Interactions of nitric oxide and superoxide dismutase in Behcet's disease. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S25-S9.
71. Sancak B, Onder M, Oztas MO, Bukan N, Gurer MA. Nitric oxide levels in Behcet's disease. J Eur Acad Dermatol Venereol 2003; 17(1): 7-9.
72. Evereklioglu C, Ozbek E, Cekmen M, et al. Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behcet's disease: Is it a new urinary activity marker? Nephrology (Carlton) 2003; 8(5): 231-38.
73. Tuzun Y, Yurdakul S, Cem MM, et al. Epidemiology of Behcet's syndrome in Turkey. Int J Dermatol 1996; 35(9): 618-20.
74. a Conferência Internacional - Paris, 1993. An Bras Dermatol 1996; 71(1): 35-42.
75. MacCormack M, Phillips T. Behçet's Disease: A Clinical Review. Wounds 2007; 14(8): 275-83.
76. Krause I, Rosen Y, Kaplan I, et al. Recurrent aphthous stomatitis in Behcet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 1999; 28(5): 193-96.
77. Borlu M, Uksal U, Ferahbas A, Evereklioglu C. Clinical features of Behcet's disease in children. Int J Dermatol 2006; 45(6): 713-16.
78. Soy M, Erken E, Konca K, Ozbek S. Smoking and Behcet's disease. Clin Rheumatol 2000; 19(6): 508-09.
79. Rizvi SW, McGrath H, Jr. The therapeutic effect of cigarette smoking on oral/genital aphthosis and other manifestations of Behcet's disease. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S77-S78.
80. Scheid P, Bohadana A, Martinet Y. Nicotine patches for aphthous ulcers due to Behcet's syndrome. N Engl J Med 2000; 343(24): 1816-17.
81. Korkmaz C, Bozan B, Kosar M, Sahin F, Gulbas Z. Is there an association of plasma homocysteine levels with vascular involvement in patients with Behcet's syndrome? Clin Exp Rheumatol 2002; 20(4 Suppl 26): S30-S34.
82. Yazici H. Behcet's syndrome: where do we stand? Am J Med 2002; 112(1): 75-76.
83. Davatchi F, Shahram F, Chams H, Chams C, Nadji A. Behçet's disease. Acta Med Iranica 2005; 43(4): 233-42.
84. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc 2003; 134(2): 200-07.
85. Evaluation of diagnostic ('classification') criteria in Behcet's disease - towards internationally agreed criteria. The International Study Group for Behcet's disease. Br J Rheumatol 1992; 31(5): 299-308.
86. Dogan B, Taskapan O, Harmanyeri Y. Prevalance of pathergy test positivity in Behcet's disease in Turkey. J Eur Acad Dermatol Venereol 2003; 17(2): 228-29.
87. Scherrer MAR, Vitral NP, Bambirra E, Oréfice F. Estudo clínico e histopatológico da patergia na doença de Behçet. An Bras Dermatol 1994; 69(4): 275-78.
88. Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ. Epidemiology of Behcet's disease in Asian countries and Japan. Adv Exp Med Biol 2003; 528: 25-29.
89. Krause I, Uziel Y, Guedj D, et al. Childhood Behcet's disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford) 1999; 38(5): 457-62.
90. Garcia CAA, Gomes AHB, Barbosa MFA, Uchôa RAC. Aspectos clínicos e epidemiológicos das uveítes em Natal - RN. Rev Bras Oftalmol 2002; 61(2): 121-29.
91. Nakae K, Masaki F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet's disease in Japan. In: Wechsler B, Godeau P, editors. Behçet's disease. Amsterdam: Excerpta Medica; 1993.
92. Siva A, Kantarci OH, Saip S, et al. Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001; 248(2): 95-103.
93. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999; 122 (Pt 11): 2171-82.
94. Samano M, Ladeira R, Meireles L, Pêgo-Fernandes P. Aneurisma de artéria pulmonar como manifestação da doença de behçet. J Pneumol 2002; 28(3): 150-54.
95. Soares J, Diógenes A, Prokopowitsch A, Broba Neto E, Neto M, Gonçalves C. Aftose bipolar na doença de Crohn ou envolvimento intestinal na doença de Behçet. Rev Bras Reumatol 2002; 42(2): 143-45.
96. Alcântara L, Trentin Júnior A, Mocellin M, Mira J, Robert F, Rosa O. Rinossinusite em paciente com síndrome de Behçet. Rev Bras Otorrinolaringol 2007; 71(2): 250-53.
97. Ng FH, Cheung TC, Chow KC, et al. Repeated intestinal perforation caused by an incomplete form of Behcet's syndrome. J Gastroenterol Hepatol 2001; 16(8): 935-39.
98. Onder M, Ozden MG, Aksakal AB, Akcali D, Babacan A, Atasever T. Raynaud phenomenon and Behcet disease: diagnosis with technetium Tc 99m methylene diphosphonate bone scan and treatment with continuous sympathetic block. Arch Dermatol 2002; 138(5): 698-699.
99. Sugihara H, Muto Y, Tsuchiyama H. Neuro-Behcet's syndrome: report of two autopsy cases. Acta Pathol Jpn 1969; 19(1): 95-101.
100. Cheng YK, Thong BY, Chng HH. Behcet's disease: experience in a tertiary rheumatology centre in Singapore and a review of the literature. Ann Acad Med Singapore 2004; 33(4): 510-14.
101. Ghate JV, Jorizzo JL. Behcet's disease and complex aphthosis. J Am Acad Dermatol 1999; 40(1): 1-18.
102. Barnes CG. Behcet's syndrome - classification criteria. Ann Med Interne (Paris) 1999; 150(6): 477-82.
103. Tunc R, Uluhan A, Melikoglu M, Ozyazgan Y, Ozdogan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome. Clin Exp Rheumatol 2001; 19(5 Suppl 24): S45-S47.
104. Curth OH. Recurrent genito-oral aphthosis with hypopyon (Beçet's syndrome). Arch Dermatol 1946; 54: 179-96.
105. Mason RM, Barnes CG. Behcet's syndrome with arthritis. Ann Rheum Dis 1969; 28(2): 95-103.
106. Mizushima Y. Recent research into Behcet's disease in Japan. Int J Tissue React 1988; 10(2): 59-65.
107. Davatchi F, Shahram F, Nadji A, et al. Performance of existing diagnosis/classification criteria for Behcet's disease in Iranian patients: analysis of 5666 patients and 2406 controls. APLAR Journal of Rheumatology 2006; 9: 238-43.
108. International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD) (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Proceedings of the 12th International Conference on Behcet's Disease. Lisbon, September 2006, Portugal.
109. Baltaci M. A review on disease activity scores in Behçet's disease. Arthritis Res Ther 2003; 5(Suppl 2): 7.
110. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford) 2004 Jan; 43(1): 73-8.
111. Souza A, Pileggi P, Hachbarth E. Tratamento com Infliximabe da doença de Behçet Ativa. Rev Bras Reumatol 2007; 45(2): 91-3.
112. Coelho K, Araújo CSA. Tratamento De Ulcerações Aftosas Recorrentes: Uma Revisão Bibliográfica. Publ UEPG Biol Health Sci 2005; 11(3/4): 39-45.
113. Gonzales-Moles MA, Morales P, Rodriguez-Archilla A, Isabel I, Gonzalez-Moles S. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93(3): 264-70.
114. Alpsoy E, Er H, Durusoy C, Yilmaz E. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet disease: a randomized, placebo-controlled, double-blind study. Arch Dermatol 1999; 135(5): 529-32.
115. Saenz AAS, Ausejo M, Shea BJ, Wells G, Welch V, Tugwell P. Pharmacotherapy for Behçet's syndrome. Cochrane Library 2007; (1).
116. Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial. Arthritis Rheum 1996; 39(12): 2062-65.
117. Calguneri M, Ertenli I, Kiraz S, Erman M, Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease. Dermatology 1996; 192(2): 125-8.
118. Al-Waiz M, Sharquie K, A-Qaissi M, Hayani R. Colchicine and benzathine penicillin in the treatment of Behcet disease: a case comparative study. Dermatol Online J 2005; 11(3): 3.
119. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38(6): 444-54.
120. Sharquie KE, Najim RA, bu-Raghif AR. Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study. J Dermatol 2002; 29(5): 267-79.
121. Siva A, Altintas A, Saip S. Behcet's syndrome and the nervous system. Curr Opin Neurol 2004; 17(3): 347-57.
122. Turk U, Aribas E, Aydin N. Cerebral venous thrombosis in Behcet's disease. Tokai J Exp Clin Med 1994; 19(1-2): 19-22.
123. Chaloupka K, Baglivo E, Hofer M, et al. Cerebral sinus thrombosis in Behcet disease: case report and review of the literature. Klin Monatsbl Augenheilkd 2003; 220(3): 186-88.
124. Limotai C, Phanthumchinda K. Cerebral venous sinus thrombosis in Behcet's disease: a case report. J Med Assoc Thai 2004; 87(7): 845-49.
125. Martin-Araguz A, Moreno-Martinez JM, Garcia de la Rocha ML, et al. Lateral sinus thrombosis in the first three months of pregnancy. Rev Neurol 1997; 25(138): 234-36.
126. Callejas J, Muñoz-Rodríguez F, Formiga F, Cervera R. Cerebral venous thrombosis in Behçet's disease: manifestation despite anticoagulant treatment. Rev Clin Esp 1998; 198(4): 263-64.
127. Hamuryudan V, Ozyazgan Y, Hizli N, et al. Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997; 40(4): 769-774.
128. Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001; 22(10): 1901-14.
129. Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 1999; 106(3): 586-89.
130. Mamo JG. Treatment of Behcet disease with chlorambucil. A follow-up report. Arch Ophthalmol 1976; 94(4): 580-83.
131. Freitas SS, Dionello CF, Rezende LS, Serrato VA, Baumle ACB, Rachid Filho A. Infliximab no tratamento de uveíte posterior refratária em paciente com doença de Behçet. Rev Bras Reumatol 2005; 45(2): 94-7.
132. Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 1998; 134(8): 1010-16.
133. Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behçet's disease: a randomized placebo-controlled and double-blind study. Arch Dermatol 2002; 138(4): 467-71.
134. Kotter I, Gunaydin I, Zierhut M, Stubiger N. The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 2004; 33(5): 320-35.
135. Demiroglu H. Behcet's disease and interferon: flaws in research integrity of randomized trial. Lancet 2000; 356(9238): 1351-1352.
136. Sfikakis PP. Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002; 61(Suppl II): ii51-ii3.
137. Merino G, Varas G, Díaz G, et al. Effectiveness of infliximab in patients with Behçet syndrome and severe uveoretinitis. Report of five cases. Rev Méd Chile 2006; 134: 875-82.
138. Fraiha PM, Bittencourt PG, Celestino RL. Estomatite Aftosa Recorrente: Revisão Bibliográfica. Rev Bras Otorrinolaringol 2002; 68(4): 571-78.
139. Neves F, Gonçalves D, Lage L, Gonçalves C. Síndrome de Behçet e Policondrite Recidivante. Rev Bras Reumatol 2006; 46(2): 157-60.
140. Adler YD, Mansmann U, Zouboulis CC. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behcet's disease. Dermatology 2001; 203(4): 322-24.
141. Lockwood CM, Hale G, Waldman H, Jayne DR. Remission induction in Behcet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H. Rheumatology (Oxford) 2003; 42(12): 1539-44.
142. Cakir N, Dervis E, Benian O, et al. Prevalence of Behcet's disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004; 22(4 Suppl 34): S53-S5.
143. Idil A, Gurler A, Boyvat A, et al. The prevalence of Behcet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 2002; 9(5): 325-31.
144. Jaber L, Milo G, Halpern GJ, Krause I, Weinberger A. Prevalence of Behcet's disease in an Arab community in Israel. Ann Rheum Dis 2002; 61(4): 365-66.
145. Al-Dalaan AN, al BS, el RK, et al. Behcet's disease in Saudi Arabia. J Rheumatol 1994; 21(4): 658-61.
146. Grana J, Sanchez-Meizoso MO, Galdo F. Epidemiological aspects of Behcet's disease in Galicia. J Rheumatol 2001; 28(11): 2565-66.
147. De Souza-Ramalho P, D'Almeida MF, Freitas JP, Pinto J. Behcet's disease in Portugal. Acta Med Port 1991; 4(2): 79-82.
148. Nilsson-Ehle H, Bremell T, Mobacken H, Norrsell K, Rodjer S. Along the Silk Road and in Sweden. Behcet's syndrome - a rare systemic disease affecting mostly younger persons. Lakartidningen 1990; 87(41): 3311-14.
149. Ambresin A, Tran T, Spertini F, Herbort C. Behcet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 2002; 10(1): 53-63.